Trials / Active Not Recruiting
Active Not RecruitingNCT03489239
Entecavir to TAF Switch
Long-term Study to Observe Safety and Efficacy of TAF in Patients With Chronic Hepatitis B
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A research study to observe the safety, efficacy and tolerability of switching from Entecavir (ETV) to Tenofovir Alafenamide TAF in patients with chronic hepatitis B
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tenofovir Alafenamide | subjects switching from Entecavir to single arm TAF 25mg |
Timeline
- Start date
- 2017-11-16
- Primary completion
- 2020-08-15
- Completion
- 2020-09-16
- First posted
- 2018-04-05
- Last updated
- 2020-06-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03489239. Inclusion in this directory is not an endorsement.